Literature DB >> 8948620

The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis.

K Hayakawa1, N Mitsuhashi, T Akimoto, K Maebayashi, H Ishikawa, K Hayakawa1, H Sakurai, T Takahashi, T Kamei, H Niibe.   

Abstract

From 1975 to 1990, 72 patients with T1 glottic cancer, excluding a verrucous type of carcinoma, were treated with radiation therapy (RT). All treatments were given with a standard fractionation of 2 Gy per day. The total dose to the tumor ranged from 60 to 70 Gy. Six patients received a split-course RT. The overall local control rate was 87% at 5 years. Forty-one patients who completed RT in 45 days or less had a 5-year local control rate of 95%. Sixteen patients who completed a treatment course in 46 to 49 days had a local control rate of 81%. Fifteen patients with a treatment course of more than 50 days had a local control rate of 73%. There was a statistically significant difference in local control rates among the three groups (P<.05). The split-course RT group had a 5-year local control rate of 50%; that rate was statistically significantly inferior to that of the continuous course group (P<.001). Multivariate analysis also showed that an interruption of the treatment course was an important parameter in relation to the local control. The prolongation of standard RT schedules adversely affected local control of T1 glottic carcinoma and, therefore, should be avoided whenever possible.

Entities:  

Mesh:

Year:  1996        PMID: 8948620     DOI: 10.1097/00005537-199612000-00020

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma.

Authors:  Ting Jin; Wei-Han Hu; Li-Bing Guo; Wen-Kuan Chen; Qiu-Li Li; Hui Lin; Xiu-Yu Cai; Nan Ge; Rui Sun; Si-Yi Bu; Xin Zhang; Meng-Yao Qiu; Wei Zhang; Su Luo; Yi-Xin Zhou
Journal:  Chin J Cancer       Date:  2011-07

2.  Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.

Authors:  Jun-Ichi Saitoh; Katsuyuki Shirai; Masumi Imaeda; Atsushi Musha; Takanori Abe; Masato Shino; Yukihiro Takayasu; Katsumasa Takahashi; Kazuaki Chikamatsu; Takashi Nakano
Journal:  Radiat Oncol       Date:  2017-02-20       Impact factor: 3.481

3.  Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer.

Authors:  Yukihisa Tamaki; Yoko Hieda; Rika Yoshida; Takeshi Yoshizako; Takafumi Fuchiwaki; Noriaki Aoi; Kazumasa Sekihara; Kazuhiro Kitajima; Hideyuki Kawauchi; Hajime Kitagaki; Ryohei Sasaki; Taisuke Inomata
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.